Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Urapidil hydrochloride freeze-dried powder for injection and preparing method thereof

A technology of urapidil hydrochloride and freeze-dried powder, applied in the field of medicine, can solve problems such as drug influence, and achieve the effects of increasing curative effect, eliminating first-pass effect, and being easy to store

Active Publication Date: 2009-07-01
SHANDONG LUOXIN PHARMA GRP CO LTD +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Similarly, the preparation process should not have the slightest ambiguity, such as the pre-freezing time, temperature, and heating time of the sublimation stage during the freeze-drying process, all of which will have a great impact on the drug.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Urapidil hydrochloride freeze-dried powder for injection and preparing method thereof
  • Urapidil hydrochloride freeze-dried powder for injection and preparing method thereof
  • Urapidil hydrochloride freeze-dried powder for injection and preparing method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] Add 27.35g of urapidil hydrochloride and 150g of mannitol into the liquid mixing tank, add 1500ml of water for injection and stir to dissolve, adjust the pH value of the solution to 5-6.5 with hydrochloric acid or sodium hydroxide, then add water for injection to 2000ml, add 0.05% (W / V) Medical activated carbon was stirred at room temperature for 40 minutes to decolorize. After decolorization, use a 0.22 μm sterilizing microporous filter membrane to fine filter. The filtrate was measured for pH value and content. The solution was frozen to -55°C for 5 hours, vacuumed to 6Pa after freezing, and slowly heated to -5°C for a heating time of 15 hours, kept at the temperature for 4 hours, then raised to 45°C for 4 hours, and then kept for 2 hours , Plugging, capping, and full inspection are packaged into the finished product warehouse.

Embodiment 2

[0054] Add 54.71g of urapidil hydrochloride and 100g of mannitol into the liquid mixing tank, add 1500ml of water for injection and stir to dissolve, adjust the pH value of the solution to 4 with hydrochloric acid or sodium hydroxide, then add water for injection to 2000ml, add 0.05% (W / V) Medical activated carbon is stirred at room temperature for 15 minutes to decolorize, and after decolorization, use a 0.22 μm sterilizing microporous filter membrane to fine filter, measure the pH value and content of the filtrate, divide it into 50 mg, half-stoppered, and freeze the divided solution to -55°C for 5 hours, vacuumize to 6Pa after freezing, slowly heat to -5°C, heating time is 15 hours, keep the temperature and heat for 4 hours, then raise the temperature to 45°C, heating time is 4 hours, then hold for 2 hours, press Plugging, capping, and full inspection are packaged into the finished product warehouse.

Embodiment 3

[0056] Add 54.71g of urapidil hydrochloride and 100g of mannitol into the liquid mixing tank, add 1500ml of water for injection and stir to dissolve, adjust the pH value of the solution to 6.5 with hydrochloric acid or potassium hydroxide, then add water for injection to 2000ml, add 0.05% (W / V) Medical activated carbon is stirred at room temperature for 15 minutes to decolorize, and after decolorization, use a 0.22 μm sterilizing microporous filter membrane to fine filter, measure the pH value and content of the filtrate, divide it into 50 mg, half-stoppered, and freeze the divided solution To -60°C, 3 hours, vacuumize to 10Pa after freezing, slowly heat to 0°C, heating time 20 hours, keep the temperature and heat for 6 hours, then heat up to 40°C, heating time 6 hours, then keep warm for 3 hours, press the plug , crimping, and full inspection are packaged into the finished product warehouse.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A freeze-dried powder of urapidil hydrochloride for injection and a preparation method thereof. The freeze-dried powder is composed of urapidil hydrochloride and a certain proportion of auxiliary materials. Its preparation is realized according to the following steps: dissolve the main and auxiliary materials in water, decolorize with activated carbon, freeze to -60~-30°C after subpackaging, 3~8 hours, vacuumize, slowly heat to 0~20°C, heating time 10 ~20 hours, keep the temperature and heat for 2~6 hours, then raise the temperature to 20~50℃, heat up for 2~6 hours, then keep warm for 0.5~4 hours, press the plug, roll the cap, and pack it into the finished product warehouse after passing the full inspection. The method adopts a gradient cooling process, and the finished product has plump appearance, good solubility, easy storage and transportation, and good stability.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a medicine for treating cardiovascular and cerebrovascular diseases and a preparation method thereof, more specifically to a freeze-dried urapidil hydrochloride powder for injection and a preparation method thereof. Background technique [0002] Hypertension is a kind of common disease, frequently-occurring disease. With the improvement of people's living standards, the number of hypertensive patients is increasing day by day, especially the number of hypertensive crisis and severe hypertensive patients is constantly increasing, but there are few safe and effective injection drugs clinically used for this type of disease. High blood pressure affects work and life, and high blood pressure is the most important risk factor for coronary heart disease and cerebrovascular disease. 50% of myocardial infarction patients are hypertensive patients, and 76% of stroke patients have a histor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/19A61K31/513A61K47/36A61K47/10A61P9/12A61P9/04
Inventor 刘保起李明华郭中明
Owner SHANDONG LUOXIN PHARMA GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com